{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:37:52Z","timestamp":1793655472596,"version":"4.5.1"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>It is well-established that individuals with type 2 diabetes mellitus (T2DM) have an increased risk of developing cognitive impairment and dementia, suggesting a close relation between hyperglycemia, insulin resistance, and chronic inflammation. This decline is characterized by a large variety of symptoms going from mild to major form of cognitive impairment characterized of loss of memory, attention, processing speed, and executive function. Preserving the physiological level of glycemia improves cognitive performance, but untreated or inadequately diabetes therapy facilitates the risk of dementia. Some experimental studies have disclosed that drug for diabetes can have protective outcomes on cognitive impairment. In this context, incretin hormone glucagon-like peptide-1 (GLP-1) can reduce blood glucose, improve glucose transport through cell membranes, and to improve brain insulin resistance modulating neuroinflammation. In fact, GLP-1 acts as a neurotransmitter and neuromodulator activating central GLP-1 receptors located in the neurons determining its neurotropic and neuroprotective role in central nervous system. Preclinical and clinical studies suggest the potential role of dipeptidyl peptidase-4 inhibitors (DPP4-i) as therapy for the treatment and prevention of cognitive impairment and dementia. Similarly, several evidences demonstrated that treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduces the risk of cognitive impairment and dementia in T2DM patients by improving learning, memory, attention and executive functions. In addition, preclinical studies suggest a possible neuroprotective effect of GLP-1\/GIP dual receptor agonist in animal models. The current narrative review, including studies published from September 1987 to September 2025, summarized the recent improvements regarding to the incretin-based therapy for cognitive impairment associated to the type 2 diabetes mellitus.<\/jats:p>","DOI":"10.3389\/fendo.2025.1696419","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:41:28Z","timestamp":1765953688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Recent advances in incretin-based therapy for the treatment of cognitive impairment associated to the type 2 diabetes mellitus: preclinical and clinical studies -\u00a0a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Federica","family":"Giofr\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Zaffina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Pelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Arturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"B1","unstructured":"Diabetes Atlas 11th Edition\n          \n          2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer\u2019s disease: From epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"ClinInterv Aging."},{"key":"B3","first-page":"503 513","article-title":"Effects of exercise on type 2 diabetes mellitus related cognitive impairment and dementia","volume":"59","author":"Callisaya","year":"2017","journal-title":"J\u202fAlzheimers Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03915.x","article-title":"Diabetes mellitus and Alzheimer\u2019s disease: shared pathology and treatment","volume":"71","author":"Akter","year":"2011","journal-title":"Br J ClinPharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between alzheimer's disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.646378","article-title":"Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans","volume":"43","author":"Kalaria","year":"2012","journal-title":"Stroke"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00118","article-title":"Insulin resistance as a link between amyloid-beta and tau pathologies in Alzheimer\u2019s disease","volume":"9","author":"Mullins","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02813432.2025.2455136","article-title":"Cognitive dysfunction in diabetes \u2013 the 'forgotten' diabetes complication: a narrative review","volume":"28","author":"Sj\u00f6holm","year":"2025","journal-title":"Scand J Prim Health Care"},{"key":"B9","article-title":"Type 2 diabetes mellitus and cognitive impairment","volume":"53","author":"Damanik","year":"2021","journal-title":"Acta Med Indones."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/0115733998279875240216093902","article-title":"Incretin therapy and insulin signaling: therapeutic targets for diabetes and associated dementia","volume":"21","author":"Joshi","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"2012","author":"McCrimmon","year":"9833","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus","volume":"301","author":"Whitmer","year":"2009","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa327","article-title":"GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists","volume":"105","author":"Holst","year":"2020","journal-title":"J ClinEndocrinolMetab."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-013-0040-0","article-title":"Incretin-based therapies: focus on effects beyond glycemic control alone","volume":"4","author":"Davidson","year":"2013","journal-title":"Diabetes Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70249-2","article-title":"Cognitive function in patients with diabetes mellitus: guidance for daily care","volume":"14","author":"Koekkoek","year":"2015","journal-title":"Lancet Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S14744422(05)702842","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104642","article-title":"Type 2 diabetes mellitus-associated cognitive Q18 dysfunction: Advances in potential mechanisms and therapies","volume":"137","author":"Luo","year":"2022","journal-title":"NeurosciBiobehav Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Definition of Alzheimer\u2019s disease (AD) is the most common form of dementia, defined by amyloid beta plaques and intracellular hyperphosphorylated tau tangles in the brain","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.9.1541","article-title":"Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset","volume":"24","author":"Northam","year":"2001","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8227(00)00195-9","article-title":"Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self management and use of care services\u2014All Wales Research into Elderly (AWARE) Study","volume":"50","author":"Sinclair","year":"2000","journal-title":"Diabetes Res ClinPract."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.52.5.971","article-title":"Longitudinal association of vascular and Alzheimer\u2019s dementias, diabetes, and glucose tolerance","volume":"52","author":"Curb","year":"1999","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/154.7.635","article-title":"Diabetes mellitus and risk of Alzheimer\u2019s disease and dementia with stroke in a multiethnic cohort","volume":"154","author":"Luchsinger","year":"2001","journal-title":"Am J Epidemiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.2.462","article-title":"Regional cerebral blood flow and cerebrovascular reactivity in IDDM","volume":"16","author":"Rodriguez","year":"1993","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-2999(02)01486-3","article-title":"Ageing and diabetes: implications for brain function","volume":"441","author":"Biessels","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(03)00503-9","article-title":"The brain in diabetes: molecular changes in neurons and their implications for end-organ damage","volume":"2","author":"Klein","year":"2003","journal-title":"Lancet Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2006.03.015","article-title":"Diabetes, leukoencephalopathy and rage","volume":"23","author":"Toth","year":"2006","journal-title":"Neurobiol Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.02.006","article-title":"N^\u03f5carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer\u2019s disease","volume":"36","author":"Girones","year":"2004","journal-title":"Free RadicBiol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.5.1306","article-title":"Diabetics do not have increased Alzheimer type pathology\u00a0compared with age-matched control subjects: a retrospective postmortemimmunocytochemical and histofluorescent study","volume":"49","author":"Heitner","year":"1997","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0712","article-title":"Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment","volume":"146","author":"Aragno","year":"2005","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(98)00485-0","article-title":"Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression","volume":"90","author":"Kamal","year":"1999","journal-title":"Neuroscience"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/BF00965566","article-title":"Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain","volume":"16","author":"Welsh","year":"1991","journal-title":"Neurochem Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00417687","article-title":"Cerebral function in diabetes mellitus","volume":"37","author":"Biessels","year":"1994","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1990.tb01403.x","article-title":"Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes","volume":"7","author":"Patrick","year":"1990","journal-title":"Diabetes Med"},{"key":"B35","article-title":"Evoked potentials in diabetes mellitus","volume":"4","author":"Comi","year":"1997","journal-title":"ClinNeurosci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189987","article-title":"Insulin and insulin resistance in Alzheimer's disease","volume":"22","author":"S\u0119dzikowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","article-title":"High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice","volume":"67","author":"Arnold","year":"2014","journal-title":"Neurobiol Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF A\u03b242 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051725","article-title":"Liraglutide suppresses tau hyperphosphorylation, amyloid beta accumulation through regulating neuronal insulin signaling and BACE\u22121 activity","volume":"21","author":"Jantrapirom","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","article-title":"Insulin-degrading enzyme in the fight against Alzheimer\u2019s disease","volume":"39","author":"Kurochkin","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-4580(99)00111-6","article-title":"Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro\u2212inflammatory pathway","volume":"21","author":"Paris","year":"2000","journal-title":"Neurobiol Aging."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411301","article-title":"Potential role of glucagon-like peptide-1 receptor agonists in the treatment of cognitive decline and dementia in diabetes mellitus","volume":"24","author":"Pelle","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF\u22121 resistance, IRS\u22121 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J ClinInvestig."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease","volume":"88","author":"De La Monte","year":"2014","journal-title":"BiochemPharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/11597760\u2212000000000\u221200000","article-title":"Contributions of brain insulin resistance and deficiency in amyloid\u2212related neurodegeneration in Alzheimer\u2019s disease","volume":"72","author":"De La Monte","year":"2012","journal-title":"Drugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD\u22122005\u22127107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014Is this Type 3 diabetes","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12065","article-title":"Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas","volume":"4","author":"Seino","year":"2013","journal-title":"J Diabetes Investig"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon\u2212like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/endo-121-3-1076","article-title":"Identification and localization of glucagon\u2212like peptide\u22121 and its receptor in rat brain","volume":"121","author":"Shimizu","year":"1987","journal-title":"Endocrinology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","article-title":"Insulin, IGF\u22121 and GLP\u22121 signaling in neurodegenerative disorders: targets for disease modification","volume":"118","author":"Bassil","year":"2014","journal-title":"ProgNeurobiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020739","article-title":"GLP\u22121a: going beyond traditional use","volume":"23","author":"Laurindo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.01.013","article-title":"The glucagon\u2212like peptide 1 (GLP\u22121) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action","volume":"21","author":"Athauda","year":"2016","journal-title":"Drug Discovery Today"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S348055","article-title":"The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in diabetes-related neurodegenerative diseases","volume":"16","author":"Cheng","year":"2022","journal-title":"Drug Des DevelTher."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00672","article-title":"Pleiotropic effects of GLP\u22121 and analogs on cell signaling, metabolism, and function","volume":"9","author":"Rowlands","year":"2018","journal-title":"Front Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1530\/JOE\u221213\u22120221","article-title":"Central effects of GLP\u22121: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"H\u00f6lscher","year":"2014","journal-title":"J Endocrinol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.825816","article-title":"Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives","volume":"12","author":"Beard","year":"2022","journal-title":"Front Physiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3579\u201315.2016","article-title":"Astrocytes regulate GLP\u20131 receptor\u2013mediated effects on energy balance","volume":"36","author":"Reiner","year":"2016","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cmet.2020.05.001","article-title":"GLP \u0301 \u20131 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function","volume":"31","author":"Timper","year":"2020","journal-title":"Cell Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.03.002","article-title":"Glucagon-like peptide-1 \u0301 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation","volume":"95","author":"Ferna\u0301ndez-Milla\u0301n","year":"2016","journal-title":"Free RadicBiol Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112493","article-title":"The role of glucagon\u2212like peptide 1 (GLP\u22121) in type 3 diabetes: GLP\u22121 controls insulin resistance, neuroinflammation and neurogenesis in the brain","volume":"18","author":"Bae","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806720106","article-title":"GLP\u22121 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl AcadSci U S A."},{"key":"B63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"303","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J PharmacolExpTher."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-19","article-title":"Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson\u2019s disease","volume":"5","author":"Harkavyi","year":"2008","journal-title":"J Neuroinflammation."},{"key":"B66","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1038\/s41598\u2212021\u221287809\u22124","article-title":"Exendin\u22124 improves long\u2212term potentiation and neuronal dendritic growth in vivo and in vitro under obesity condition","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02113-z","article-title":"Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials","volume":"28","author":"Basheer","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2174\/1567205014666170317113606","article-title":"Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological hallmarks","volume":"14","author":"Domingues","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-783","article-title":"Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00718-2","article-title":"Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt\/b-catenin\/NeuroD1 pathway","volume":"29","author":"Kang","year":"2023","journal-title":"Mol Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e12268","DOI":"10.1002\/trc2.12268","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"Norgaard","year":"2022","journal-title":"Alzheimers Dement (N Y)."},{"key":"B73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1515\/revneuro\u22122015\u22120021","article-title":"Neuroprotective effects of glucose\u2212dependent insulinotropic polypeptide in Alzheimer\u2019s disease","volume":"27","author":"Ji","year":"2016","journal-title":"Rev Neurosci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.10.059","article-title":"Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high\u2212fat fed mice","volume":"650","author":"Porter","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ejphar.2011.11.007","article-title":"Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice","volume":"674","author":"Faivre","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt174","article-title":"Neuroprotective effects of D\u2212Ala^2GIP on Alzheimer\u2019s disease biomarkers in an APP\/PS1 mouse model","volume":"5","author":"Faivre","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15045596","article-title":"Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide","volume":"15","author":"Maino","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD\u2212201262","article-title":"DAla2\u2212GIP\u2212GLU\u2212PAL protects against cognitive deficits and pathology in APP\/PS1 mice by inhibiting neuroinflammation and upregulating cAMP\/PKA\/CREB signaling pathways","volume":"80","author":"Yuan","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1177\/20587392211070402","article-title":"Glucose\u2212dependent insulinotropic polypeptide and tissue inflammation: implications for atherogenic cardiovascular disease","volume":"20","author":"He","year":"2022","journal-title":"Eur J Inflam."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2017.03.004","article-title":"Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors","volume":"96","author":"Spielman","year":"2017","journal-title":"Eur J Cell Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31068","article-title":"Biological actions and therapeutic potential of the glucagon-like peptides","volume":"122","author":"Drucker","year":"2002","journal-title":"Gastroenterology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.09.003","article-title":"Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus","volume":"11","author":"Gupta","year":"2017","journal-title":"Diabetes MetabSyndr."},{"key":"B84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-642-17214-4_3","article-title":"GLP-1 agonists and dipeptidyl-peptidase IV inhibitors","author":"Gallwitz","year":"2011","journal-title":"HandbExpPharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012626","article-title":"Association of dipeptidyl peptidase-4 inhibitor use and amyloid burden in patients with diabetes and AD-related cognitive impairment","volume":"97","author":"Jeong","year":"2021","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1038\/s41598-018-21894-5","article-title":"Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropathic pain","volume":"8","author":"Kir\u00e1ly","year":"2018","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114689","article-title":"DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice","volume":"373","author":"Zhuge","year":"2024","journal-title":"Exp Neurol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.04.008","article-title":"Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease","author":"Kosaraju","year":"2013","journal-title":"Neuropharmacology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0117-0","article-title":"Linagliptin, a dipeptidyl peptidase-4 inhibitor, mitigates cognitive deficits and pathology in the 3xTg-AD mouse model of Alzheimer's disease","volume":"54","author":"Kosaraju","year":"2017","journal-title":"MolNeurobiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12148","article-title":"Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease","volume":"65","author":"Kosaraju","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbr.2014.03.007","article-title":"Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease","volume":"267","author":"Kosaraju","year":"2014","journal-title":"Behav Brain Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"255","DOI":"10.21037\/atm.2018.04.41","article-title":"DPP-4 inhibitors: a promising therapeutic approach against Alzheimer's disease","volume":"6","author":"Angelopoulou","year":"2018","journal-title":"Ann Transl Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt154","article-title":"Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment","volume":"69","author":"Rizzo","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2016.11.006","article-title":"The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease","volume":"123","author":"Isik","year":"2017","journal-title":"Diabetes Res ClinPract."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e58819","DOI":"10.1371\/journal.pone.0058819","article-title":"Sirtuin1: a promising serum protein marker for early detection of Alzheimer's disease","volume":"8","author":"Kumar","year":"2013","journal-title":"PloS One"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12338","article-title":"DPP-4 Inhibitor Linagliptin Attenuates Abeta-induced Cytotoxicity through Activation of AMPK in Neuronal Cells","volume":"21","author":"Kornelius","year":"2015","journal-title":"CNS NeurosciTher."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.12.035","article-title":"SIRT1 in neurodevelopment and brain senescence","volume":"81","author":"Herskovits","year":"2014","journal-title":"Neuron"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2012.648970","article-title":"SIRT1: new avenues of discovery for disorders of oxidative stress","volume":"16","author":"Chong","year":"2012","journal-title":"Expert OpinTher Targets."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010028","article-title":"Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study","volume":"8","author":"Kim","year":"2018","journal-title":"J Clin Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12161","article-title":"Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status","volume":"16","author":"Wu","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1033479","article-title":"The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer\u2019s disease","volume":"13","author":"Du","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110688","article-title":"Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes","volume":"200","author":"Longo","year":"2023","journal-title":"Diabetes Res ClinPract."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.09.064","article-title":"Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer\u2019s disease","volume":"630","author":"McClean","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.04.009","article-title":"Liraglutide protects against amyloid-\u03b2 protein-induced impairment of spatial learning and memory in rats","volume":"34","author":"Han","year":"2013","journal-title":"Neurobiol Aging."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J Neurosci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.08.013","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e58784","DOI":"10.1371\/journal.pone.0058784","article-title":"Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PloS One"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-013-8224-8","article-title":"The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-\u03b2 plaque and glial pathology in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Long-Smith","year":"2013","journal-title":"Neuromolecular Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2016.12.028","article-title":"Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects","volume":"321","author":"Palleria","year":"2017","journal-title":"Behav Brain Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0716-8","article-title":"Brain GLP-1\/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats","volume":"55","author":"Candeias","year":"2018","journal-title":"MolNeurobiol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/118140","article-title":"The role of GLP-1\/GIP receptor agonists in Alzheimer\u2019s disease","volume":"29","author":"Yu","year":"2020","journal-title":"AdvClinExp Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15125","article-title":"The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration","volume":"159","author":"Li","year":"2021","journal-title":"J Neurochem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01183-5","article-title":"Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer\u2019s disease","volume":"9","author":"Park","year":"2021","journal-title":"ActaNeuropatholCommun"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23262","article-title":"Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents","volume":"92","author":"Iwai","year":"2014","journal-title":"J Neurosci Res"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111529","article-title":"Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer\u2019s disease by suppressing NLRP2 activation in astrocytes","volume":"542","author":"Zhang","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70500","article-title":"Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury","volume":"18","author":"Qian","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2012.01.013","article-title":"The effect of ageing on neurogenesis and oxidative stress in the APP(swe)\/PS1(deltaE9) mouse model of Alzheimer\u2019s disease","volume":"1449","author":"Hamilton","year":"2012","journal-title":"Brain Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2021.107463","article-title":"GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK\/NF-\u03baB pathway in neuropathic pain mice","volume":"182","author":"Zhang","year":"2021","journal-title":"Neurobiol Learn Mem"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.03.031","article-title":"Balance and stability of synaptic structures during synaptic plasticity","volume":"82","author":"Meyer","year":"2014","journal-title":"Neuron"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179583","article-title":"Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases","volume":"23","author":"Diz-Chaves","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-335593","article-title":"Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders","volume":"96","author":"De Giorgi","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B122","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13195-024-01573-x","article-title":"Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial","volume":"16","author":"Koychev","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251319054","article-title":"Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis","volume":"104","author":"Hui","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11481-024-10142-w","article-title":"Semaglutide attenuates anxious and depressive-like behaviors and reverses the cognitive impairment in a type 2 diabetes mellitus mouse model via the microbiota-gut-brain axis","volume":"19","author":"dePaiva","year":"2024","journal-title":"J NeuroimmunePharmacol."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R\/SIRT1\/GLUT4 pathway","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2024.11.022","article-title":"Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP\/PS1\/tau mice","volume":"563","author":"Wang","year":"2024","journal-title":"Neuroscience"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102019","article-title":"The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP\/PS1 mice","volume":"89","author":"FornyGermano","year":"2024","journal-title":"Mol Metab"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2174\/1567205016666190109111532","article-title":"A Pilot Study of Exenatide Actions in Alzheimer\u2019s Disease","volume":"16","author":"Mullins","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/acps.12661","article-title":"No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia","volume":"136","author":"Ish\u00f8y","year":"2017","journal-title":"ActaPsychiatr Scand"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13063-019-3271-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer\u2019s disease: Study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-020-0560-9","article-title":"Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: A randomized, controlled study","volume":"44","author":"Vadini","year":"2020","journal-title":"Int J Obes (Lond)."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e020734","DOI":"10.1161\/JAHA.121.020734","article-title":"Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway","volume":"10","author":"Li","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2018.02.024","article-title":"Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients","volume":"174","author":"Wu","year":"2018","journal-title":"ClinNeurolNeurosurg"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2475","article-title":"Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients with Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study","volume":"45","author":"Cheng","year":"2022","journal-title":"Diabetes Care"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30104-0","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: An exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-025-00990-x","article-title":"evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer\u2019s disease","volume":"17","author":"Cummings","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14313","article-title":"Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B139","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e72080","DOI":"10.7759\/cureus.72080","article-title":"Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders","volume":"16","author":"Olukorode","year":"2024","journal-title":"Cureus"},{"key":"B141","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11011-025-01649-z","article-title":"Tirzepatide: a novel therapeutic approach for Alzheimer's disease","volume":"40","author":"Alshehri","year":"2025","journal-title":"Metab Brain Dis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04013-w","article-title":"Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis","volume":"87","author":"Ma","year":"2025","journal-title":"Endocrine"},{"key":"B143","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12967-024-04927-z","article-title":"Tirzepatide prevents neurodegeneration through multiple molecular pathways","volume":"22","author":"Fontanella","year":"2024","journal-title":"J Transl Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41419-018-0253-6","article-title":"Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101402","article-title":"A novel role of CRTC2 in promoting nonalcoholic fatty liver disease","volume":"55","author":"Han","year":"2022","journal-title":"MolMetab"},{"key":"B146","doi-asserted-by":"publisher","first-page":"16714","DOI":"10.1038\/s41598-020-73698-6","article-title":"Acrylamide alters CREB and retinoic acid signalling pathways during differentiation of the human neuroblastoma SH-SY5Y cell line","volume":"10","author":"Attoff","year":"2020","journal-title":"Sci Rep"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0367-19.2019","article-title":"CREB family transcription factors are major mediators of bdnf transcriptional autoregulation in cortical neurons","volume":"40","author":"Esvald","year":"2020","journal-title":"J Neurosci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.07080.x","article-title":"CREB: a multifaceted regulator of neuronal plasticity and protection","volume":"116","author":"Sakamoto","year":"2011","journal-title":"J Neurochem"},{"key":"B149","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00629","article-title":"Altered insulin signaling in Alzheimer\u2019s disease brain\u2013special emphasis on PI3K-Akt pathway","volume":"13","author":"Gabbouj","year":"2019","journal-title":"Front Neurosci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5448.2358","article-title":"Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons","volume":"286","author":"Riccio","year":"1999","journal-title":"Science"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1177\/0960327117703687","article-title":"Effects of cadmium on Bcl-2\/Bax expression ratio in rat cortex brain and hippocampus","volume":"37","author":"Mahdavi","year":"2018","journal-title":"Hum ExpToxicol."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.599543","article-title":"Baicalin attenuates oxygen-glucose deprivation\/reoxygenation-induced injury by modulating the BDNF-TrkB\/PI3K\/Akt and MAPK\/Erk1\/2 signaling axes in neuron-astrocyte cocultures","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2017.11.006","article-title":"Effects and mechanisms of matrix metalloproteinase-2 on neural differentiation of induced pluripotent stem cells","volume":"1678","author":"Shu","year":"2018","journal-title":"Brain Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.04.083","article-title":"Dynamic association of p300 with the promoter of the G protein-coupled rat delta opioid receptor gene during NGF-induced neuronal differentiation","volume":"396","author":"Chen","year":"2010","journal-title":"BiochemBiophys Res Commun"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.5.658","article-title":"Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients","volume":"23","author":"Marfella","year":"2000","journal-title":"Diabetes Care"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-224","article-title":"Human conditions of insulin-like growth factor-I (IGF-I) deficiency","volume":"10","author":"Puche","year":"2012","journal-title":"J Transl Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5805","article-title":"The biological functions and mechanism of miR-212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2","volume":"38","author":"Zhou","year":"2017","journal-title":"Oncol Rep"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05037-7","article-title":"A novel Dual GLP-1\/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5\u2009\u00d7 FAD Alzheimer Mouse Model","volume":"62","author":"Ma","year":"2025","journal-title":"Mol Neurobiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1696419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:41:37Z","timestamp":1765953697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1696419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":159,"alternative-id":["10.3389\/fendo.2025.1696419"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1696419","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1696419"}}